{"id":"W2588989861","doi":"10.1093/annonc/mdw435.04","title":"FALCON: A phase III randomised trial of fulvestrant 500 mg vs. anastrozole for hormone receptor-positive advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Fulvestrant; Anastrozole; Medicine; Hazard ratio; Clinical endpoint; Internal medicine; Oncology; Breast cancer; Adverse effect; Estrogen receptor; Cancer; Clinical trial; Confidence interval; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009716598,0.001505375,0.001461228,0.000432346,0.0003022305,0.0008741328,0.0009555835,0.001253425,0.01149992],"category_scores_gemma":[0.001169619,0.0003770965,0.001033478,0.000373883,0.0009872622,0.0009701049,0.0003663874,0.002259329,0.001282987],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001006928,"about_ca_system_score_gemma":0.0008800988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002073467,"about_ca_topic_score_gemma":0.005410843,"domain_scores_codex":[0.9997328,0.0001416235,0.000009310213,0.00003518748,0.00002057983,0.00006049551],"domain_scores_gemma":[0.9995791,0.0001415799,0.00006655228,0.00003497426,0.00001983589,0.0001579144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9679824,0.003073568,0.0006162251,0.0003692084,0.0005673724,0.00005076221,0.00003849346,0.0007429351,0.003069593,0.0002731008,0.002137718,0.02107869],"study_design_scores_gemma":[0.9546666,0.04106029,0.001768507,0.00002187762,0.0002362572,0.00005005236,0.00004114286,0.0004781399,0.0002749503,0.0002702862,0.001118398,0.00001357409],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860997,0.003358125,0.0004848147,0.001534994,0.0006421346,0.001502234,0.001881995,0.0002430397,0.004252889],"genre_scores_gemma":[0.9816788,0.002143073,0.0009696076,0.001812646,0.0003312347,0.002109068,0.002917904,0.0000458322,0.007992042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01149992,"threshold_uncertainty_score":0.03847104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01885117931135382,"score_gpt":0.3469741085115958,"score_spread":0.328122929200242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}